Simplex Trading
LKFT

Simplex Trading’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Simplex Trading’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$753K Buy
25,100
+24,500
+4,083% +$811K ﹤0.01% 2795
2025
Q4 		$19.6K Sell
600
-900
-60% -$29.1K ﹤0.01% 6490
2025
Q3 		$51K Buy
1,500
+100
+7% +$3.2K ﹤0.01% 6440
2025
Q2 		$39K Sell
1,400
-800
-36% -$21.4K ﹤0.01% 6166
2025
Q1 		$55K Buy
2,200
+1,400
+175% +$35.4K ﹤0.01% 5660
2024
Q4 		$22K Sell
800
-600
-43% -$16.7K ﹤0.01% 6605
2024
Q3 		$40K Sell
1,400
-30,600
-96% -$833K ﹤0.01% 6084
2024
Q2 		$792K Buy
32,000
+26,400
+471% +$749K ﹤0.01% 3165
2024
Q1 		$180K Sell
5,600
-8,800
-61% -$327K ﹤0.01% 4976
2023
Q4 		$585K Sell
14,400
-2,000
-12% -$73.6K ﹤0.01% 3525
2023
Q3 		$566K Sell
16,400
-37,400
-70% -$1.46M ﹤0.01% 3262
2023
Q2 		$2.19M Sell
53,800
-19,200
-26% -$783K ﹤0.01% 1911
2023
Q1 		$2.82M Buy
73,000
+42,300
+138% +$1.74M ﹤0.01% 1672
2022
Q4 		$1.36M Buy
30,700
+24,300
+380% +$1.02M ﹤0.01% 2181
2022
Q3 		$272K Buy
6,400
+2,000
+45% +$102K ﹤0.01% 4210
2022
Q2 		$245K Sell
4,400
-23,200
-84% -$1.38M ﹤0.01% 4364
2022
Q1 		$1.71M Buy
27,600
+26,000
+1,625% +$1.59M ﹤0.01% 2269
2021
Q4 		$88K Sell
1,600
-2,900
-64% -$151K ﹤0.01% 6456
2021
Q3 		$315K Hold
4,500
– – ﹤0.01% 4829
2021
Q2 		$310K Buy
4,500
+4,340
+2,713% +$331K ﹤0.01% 4927
2021
Q1 		$1.23M Buy
+160
New +$14.7K ﹤0.01% 2162
2020
Q4 		– Sell
-54
Closed -$766K – 8584
2020
Q3 		$766K Buy
54
+2
+4% +$333 ﹤0.01% 2539
2020
Q2 		$1.02M Sell
52
-1
-2% -$207 ﹤0.01% 2129
2020
Q1 		$1.04M Sell
53
-149
-74% -$32.1K ﹤0.01% 1847
2019
Q4 		$4.18M Buy
202
+59
+41% +$10.9K 0.01% 919
2019
Q3 		$2.18M Sell
143
-212
-60% -$34.7K 0.01% 1273
2019
Q2 		$4.58M Buy
355
+227
+177% +$26.9K 0.01% 726
2019
Q1 		$1.51M Buy
+128
New +$12.9K ﹤0.01% 1626
2018
Q1 		– Sell
-2
Closed -$1K – 6391
2017
Q4 		$1K Buy
+2
New +$189 ﹤0.01% 5507
2017
Q3 		– Sell
-2
Closed -$8K – 6147
2017
Q2 		$8K Buy
+2
New +$168 ﹤0.01% 4162

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Simplex Trading's LKFT Position: Q1 2026 in Review

Simplex Trading increased its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 9,666% in Q1 2026, buying an estimated $237K and bringing the position to 7,227 shares worth $217K. The position accounts for ﹤0.01% of the portfolio, ranked #4214.

Simplex Trading first reported a position in LKFT in Q2 2017 and has held it in 18 quarters since. The position peaked at $3.73M in Q2 2020. 90 funds tracked by Wall St. Rank hold LKFT as of Q1 2026.

  • Simplex Trading held 7,227 shares of Lakefront Biotherapeutics American Depositary Shares worth $217K as of Q1 2026.
  • Simplex Trading bought 7,153 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2026, an estimated $237K.
  • Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #4214 holding.
  • Simplex Trading first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2017 and has held it in 18 quarters since.
  • Simplex Trading's Lakefront Biotherapeutics American Depositary Shares position peaked at $3.73M in Q2 2020.
  • 90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.